Centre De Recherche Du Centre Hospitalier Universitaire De Sherbrooke
Clinical trials sponsored by Centre De Recherche Du Centre Hospitalier Universitaire De Sherbrooke, explained in plain language.
-
New PET tracer could reveal hidden breast cancer throughout the body
Diagnosis Recruiting nowThis phase 2 trial tests a new radioactive tracer called 4FMFES for PET scans in people with advanced estrogen receptor positive (ER+) breast cancer. The tracer binds to estrogen receptors, allowing doctors to see where the cancer has spread anywhere in the body. The study aims t…
Phase: PHASE2 • Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
New scan could sharpen detection of childhood cancer
Diagnosis Recruiting nowThis study tests a new type of PET/CT scan using a radioactive tracer called 68Ga-DOTATATE to see if it can detect neuroblastoma tumors better than the current standard scan (123I-MIBG). The study will enroll 20 children and young adults with suspected or confirmed neuroblastoma.…
Phase: PHASE2 • Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Could a new scan unlock better breast cancer treatment?
Diagnosis Recruiting nowThis study tests a special PET scan using a radioactive tracer called 89Zr-trastuzumab to find low levels of HER2 in metastatic breast cancer. Researchers aim to see if this scan can better detect tumors that might respond to newer drugs like Enhertu. The trial will involve 40 ad…
Phase: PHASE1, PHASE2 • Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC